Skip to content

A clinical trial to study the effect of selective Siddha medicines in the treatment of Alcohol withdrawal syndrome

Therapeutic efficacy of selective Siddha medicines in the management of Alcohol withdrawal syndrome-An open clinical study

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/10/028266
Enrollment
10
Registered
2020-10-07
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F109- Alcohol use, unspecified

Interventions

Intervention1: 1.INJI RASAYANAM. 2.BRAHMI NEI. 3.AMUKKARA CHOORANAM.: 1.INJI RASAYANAM Dosage: 3-6 gm (2 times per day) Adjuvant: Warm water Duration: 48 days 2.BRAHMI NEI Dosage: 8-15 ml (2 times per

Sponsors

Ayothidass pandithar hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients had history of alcoholism between 1 to 20 years 2.Binge drinkers ( >4 drinks /occasion) 3.AWS in Oriented patients 4.Patient having history of alcohol consumption and symptoms like Nausea and vomiting, Tremor, Paroxysmal sweats, Anxiety, Agitation, Tactile disturbance, Auditory disturbance, visual disturbance, Headache and Fullness in head. 5.Patients who have more than 3 symptoms.

Exclusion criteria

Exclusion criteria: 1.CNS disorders 2.Psychiatric disorders 3.Chronic liver diseases 4.Other Norcopic drug users 5.Withdrawal symptoms like Seizure, delirium, hallucination 6.Systemic diseases

Design outcomes

Secondary

MeasureTime frame
characteristics of Alcohol withdrawal syndrome in patientsTimepoint: 48 days

Primary

MeasureTime frame
Outcome of the study will be assessed by using Clinical Institute Withdrawal Assessment of Alcohol Scale (CIWA-Ar).Timepoint: 48 days

Countries

India

Contacts

Public ContactDr E Selvasankari

National institute of siddha

drmanjarimd@gmail.com8056903083

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026